Drug for treatment of human liver diseases

Abstract

The invention relates to the technical field of medicine, specifically to a drug for treatment of human liver diseases. The drug is prepared from the following materials by weight: 15-30 parts of Astragalus, 10-20 parts of radix paeoniae rubra, 10-20 parts of turtle shell, 10-20 parts of bighead atractylodes rhizome, 15-25 parts of semen plantaginis, 5-12 parts of radix bupleuri, 5-15 parts of cyperus rotundus, 15-30 parts of hawthorn, 15-30 parts of Poria cocos, 10-20 parts of raw rehmannia root, 6-10 parts of Codonopsis pilosula, 10-20 parts of Salvia Miltiorrhiza, 10-20 parts of polygonum cuspidatum, 10-20 parts of dwarf lilyturf tuber, 10-20 parts of radix aucklandiae, 15-20 parts of Mylopharyngodon piceus gall bladder, 20-40 parts of Lonicera japonica, 2-4 parts of musk, 2-5 parts of rhinoceros horn, and 6-9 parts of antelope horn. The invention aims to provide the drug for treatment of human liver diseases with the characteristics of strong pertinency and ideal effect.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a medicine for treating human liver diseases. Background technique [0002] Liver disease mainly enters the blood through virus infection, and there are many ways of infection, which are difficult to control and have a high incidence rate. At present, the rate of patients with liver disease has increased nationwide, but both Chinese and Western medicine are difficult to cure liver cirrhosis and ascites. At present, there are many traditional Chinese and Western medicines for the treatment of liver diseases. Western medicines use conventional hepatoprotective drugs, dihydrochlorothiazide, spironolactone and other drugs. In recent years, clinical practice believes that western medicine has quick results, but the maintenance time is short. Improper medication leads to electrolyte imbalance. , the recurrence rate is relatively high, and some western medicines are expensive, and are...

AI Technical Summary

Problems solved by technology

[0002] Liver disease mainly enters the blood through virus infection. There are many ways of infection, difficult to control, and high incidence

At present, the rate of patients with liver disease has increased nationwide, but both Chinese and Western medicine are difficult to cure liver cirrhosis and ascites

At present, there are many traditional Chinese and Western medicines for the treatment of liver diseases. Western medicines use conventional hepatoprotective drugs, dihydrochlorothiazide, spironolactone and other drugs. In recent years, clinical practice believes that western medicine has quick results, but the maintenance time is short. Improper medication leads to electrolyte imbalance. , the recurrence rate is relatively high, and some western medicines are expensive, and are not easily accepted by patients. Western medicine treatment methods must be hospitalized for observation, which increases the financial burden of patients. However, some medicines in traditional Chinese medicine treatment are poorly targeted and cannot be treated according to different types. not ideal